ClinConnect ClinConnect Logo
Search / Trial NCT06580847

Benefits of Choir for Older Adults with Unaddressed Hearing Loss (WP2)

Launched by TORONTO METROPOLITAN UNIVERSITY · Aug 29, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Hearing Loss Speech In Noise Psychosocial Wellbeing

ClinConnect Summary

This clinical trial, called the SingWell Project, is exploring whether group singing can help older adults with unaddressed hearing loss. Many people over 60 experience hearing loss that isn’t treated, which can make it hard to understand conversations, especially in noisy environments, and can negatively affect their social well-being. The researchers aim to find out if joining a choir for 12 weeks can improve how well participants hear and their overall happiness compared to those who join an audiobook club instead.

To participate, individuals need to be at least 60 years old and have mild to moderate hearing loss that hasn’t been treated with hearing aids or other devices. They should also be mentally fit enough to understand the study activities. The study plans to recruit 210 participants who will be split into two groups—one for singing and one for listening to audiobooks. Throughout the trial, participants will complete various assessments to measure their hearing and emotional health before and after the study period. This research could provide valuable insights into how group singing might benefit older adults facing hearing challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adults aged 60 years and older;
  • 2. Bilateral mild-to-moderate hearing loss (20-49 dB hearing level), measured using four-frequency pure-tone average across both ears (4FPTA) measured at 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz;
  • 3. Unaddressed hearing loss (i.e., participants must not currently use a hearing aid, cochlear implant, or assistive listening device);
  • 4. No significant cognitive impairment, to be assessed with the Montreal Cognitive Assessment for people with hearing impairment (MoCA-H), with participants requiring a score ≥ 24;
  • 5. Not use a pacemaker or anti-arrhythmic agents/medications;
  • 6. Not currently participating in regular active music learning (e.g., choir, formal music training) or audiobook clubs within the last year; and
  • 7. Sufficient language capacity to understand and complete the test materials. Note: all materials will be presented written and/or aurally in English at the sites located in Canada, United States of America, and Australia; Dutch at the Netherlands site; and German at the Germany site.

About Toronto Metropolitan University

Toronto Metropolitan University (TMU) is a leading urban institution dedicated to fostering innovative research and academic excellence. As a clinical trial sponsor, TMU leverages its interdisciplinary expertise and cutting-edge facilities to conduct impactful research that addresses pressing health challenges. Through collaboration with healthcare professionals, industry partners, and community stakeholders, TMU aims to translate scientific discoveries into practical solutions, enhancing patient care and advancing public health. Committed to ethical standards and rigorous methodologies, TMU ensures the integrity and reliability of its clinical trials, contributing to the advancement of medical knowledge and practice.

Locations

Adelaide, South Australia, Australia

Toronto, Ontario, Canada

Saint John's, Newfoundland And Labrador, Canada

Los Angeles, California, United States

Montréal, Quebec, Canada

Oldenburg, , Germany

Groningen, , Netherlands

Patients applied

0 patients applied

Trial Officials

Frank Russo, PhD

Study Director

Toronto Metropolitan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported